Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection
Pan-Pan Zhou, Meng Yuan, Ge Song, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 637
Open Access | Times Cited: 160

Showing 1-25 of 160 citing articles:

Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
Yanjia Chen, Xiaoyu Zhao, Hao Zhou, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 189-199
Open Access | Times Cited: 272
Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 233
Monoclonal antibody therapies against SARS-CoV-2
Daniele Focosi, Scott A. McConnell, Arturo Casadevall, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 11, pp. e311-e326
Open Access | Times Cited: 204
Broadly neutralizing antibodies target the coronavirus fusion peptide
Cherrelle Dacon, Courtney Tucker, Linghang Peng, et al.
Science (2022) Vol. 377, Iss. 6607, pp. 728-735
Open Access | Times Cited: 187
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
Jun Siong Low, Josipa Jerak, M. Alejandra Tortorici, et al.
Science (2022) Vol. 377, Iss. 6607, pp. 735-742
Open Access | Times Cited: 139
Antibody-mediated neutralization of SARS-CoV-2
Henning Gruell, Kanika Vanshylla, Timm Weber, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 925-944
Open Access | Times Cited: 117
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease
Pan-Pan Zhou, Ge Song, Hejun Liu, et al.
Immunity (2023) Vol. 56, Iss. 3, pp. 669-686.e7
Open Access | Times Cited: 111
Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2
Xiaoyu Sun, Chunyan Yi, Yuanfei Zhu, et al.
Nature Microbiology (2022) Vol. 7, Iss. 7, pp. 1063-1074
Open Access | Times Cited: 110
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
Sam M. Murray, M. Azim Ansari, John Frater, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 5, pp. 304-316
Open Access | Times Cited: 110
Close relatives of MERS-CoV in bats use ACE2 as their functional receptors
Qing Xiong, Lei Cao, Chengbao Ma, et al.
Nature (2022) Vol. 612, Iss. 7941, pp. 748-757
Open Access | Times Cited: 100
A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2
Yiquan Wang, Meng Yuan, Huibin Lv, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 1105-1117.e4
Open Access | Times Cited: 85
Antiviral Drug Discovery for the Treatment of COVID-19 Infections
Teresa I. Ng, Ivan Correia, Jane Seagal, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 961-961
Open Access | Times Cited: 77
SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines
John E. Bowen, Young‐Jun Park, Cameron Stewart, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 70
Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses
Rui P. Silva, Yimin Huang, Annalee W. Nguyen, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 64
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein
Filippo Bianchini, Virginia Crivelli, Morgan E. Abernathy, et al.
Science Immunology (2023) Vol. 8, Iss. 81
Open Access | Times Cited: 58
Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans
M. Alejandra Tortorici, Amin Addetia, Albert J. Seo, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 904-911.e4
Open Access | Times Cited: 51
Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines
Liyan Guo, Sheng Lin, Zimin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 44
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines
Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Nature (2024) Vol. 630, Iss. 8018, pp. 950-960
Closed Access | Times Cited: 29
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses
Wanting He, Rami Musharrafieh, Ge Song, et al.
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 960-970
Open Access | Times Cited: 56
Challenges and developments in universal vaccine design against SARS-CoV-2 variants
Fangxin Zhao, Xiaodong Zai, Zhiling Zhang, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 56
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Wei Pang, Ying Lu, Yan‐Bo Zhao, et al.
Cell Research (2022) Vol. 32, Iss. 12, pp. 1068-1085
Open Access | Times Cited: 51
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses
Mingxi Li, Yifei Ren, Zhen Qin Aw, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 46
Protective neutralizing epitopes in SARS‐CoV‐2
Hejun Liu, Ian A. Wilson
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 76-92
Open Access | Times Cited: 39
Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses
Cherrelle Dacon, Linghang Peng, Ting-Hui Lin, et al.
Cell Host & Microbe (2022) Vol. 31, Iss. 1, pp. 97-111.e12
Open Access | Times Cited: 39
SARS-CoV-2 spike S2-specific neutralizing antibodies
Chia‐Jung Li, Shih‐Chung Chang
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top